Bioequivalence Study betweenYHP2407 and YHR2502 in Healthy Subjects

NCT06926387 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: YHP2407
DRUG: YHR2502

Sponsor

Yuhan Corporation